CSBIO(SZ:300255) Sou Hu Cai Jing·2025-10-13 02:36Core Insights - The financing buy-in for Changshan Pharmaceutical (300255) on October 10 was 97.42 million yuan, with a net buy of 1.32 million yuan, indicating a positive investor sentiment [1][3] - The financing balance reached 1.95 billion yuan, showing a slight increase of 0.07% from the previous day [3][4] - Over the past three trading days, the cumulative net buy amounted to 29.49 million yuan, with 11 out of the last 20 trading days showing net buying activity [1][2] Financing Activity Summary - On October 10, the net financing buy was 1.32 million yuan, with a financing balance of 1.95 billion yuan, representing 4.29% of the circulating market value [2] - The financing balance has shown fluctuations, with a previous day's net buy of 23.43 million yuan and a balance of 1.949 billion yuan [2][4] - The financing balance has increased from 1.921 billion yuan on September 29 to 1.95 billion yuan on October 10, reflecting a general upward trend in investor activity [4] Market Sentiment Analysis - An increase in financing balance typically indicates a bullish market sentiment, suggesting that investors are leaning towards buying [5] - The recent net buying activity suggests a growing confidence among investors in Changshan Pharmaceutical's stock performance [1][5]